Tsukasa Oda

8PUBLICATIONS
12CO-AUTHORS
Molecular targetsHaematological tumoursTumour immunologyMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 13, 2025
Role of Rac1 in p53-Related Proliferation and Drug Sensitivity in Multiple Myeloma.

Ikuko Matsumura, Tsukasa Oda, Tetsuhiro Kasamatsu

|Nov 13, 2024
APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation.

Nanami Gotoh, Tsukasa Oda, Yuya Kitamura

|Feb 11, 2023
Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.

Rei Ishihara, Tsukasa Oda, Yuki Murakami

|Jan 21, 2023
MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression.

Yuki Murakami, Kei Kimura-Masuda, Tsukasa Oda

|Jan 16, 2023
DNA damage-induced cellular senescence is regulated by 53BP1 accumulation in the nuclear foci and phase separation.

Tsukasa Oda, Nanami Gotoh, Tetsuhiro Kasamatsu

|Feb 23, 2021
DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway.

Tsukasa Oda, Ruri Nakamura, Tetsuhiro Kasamatsu

Pageof 2

Frequent Collaborators

6 joint publications

Hiroshi Handa

5 joint publications

Tetsuhiro Kasamatsu

4 joint publications

Nobuo Sasaki

3 joint publications

Takayuki Saitoh